ES437012A1 - Un procedimiento para la preparacion de derivados de bencil-pirimidina. - Google Patents

Un procedimiento para la preparacion de derivados de bencil-pirimidina.

Info

Publication number
ES437012A1
ES437012A1 ES437012A ES437012A ES437012A1 ES 437012 A1 ES437012 A1 ES 437012A1 ES 437012 A ES437012 A ES 437012A ES 437012 A ES437012 A ES 437012A ES 437012 A1 ES437012 A1 ES 437012A1
Authority
ES
Spain
Prior art keywords
hydracide
diphenyl
mono
butylmalonic acid
cupric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437012A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES437012A1 publication Critical patent/ES437012A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE LA SAL CUPRICA DE LA MONO-(1,2-DIFENILHIDRACIDA) DEL ACIDO BUTILMALONICO. SE HACE REACCIONAR LA MONO-(1,2-DIFENILHIDRACIDA) DEL ACIDO BUTILMALONICO CON SALES CUPRICAS DE ACIDOS ORGANICOS DEBILES (PREFERENTEMENTE EL ACETATO), SALES BASICAS DE COBRE DIVALENTE O CON HIDROXIDO CUPRICO. LA REACCION SE PUEDE LLEVAR A CABO EN MEDIO HOMOGENEO O HETEROGENEO. EL PRODUCTO TIENE ACCION ANTIINFLAMATORIA.
ES437012A 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina. Expired ES437012A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (es) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
ES437012A1 true ES437012A1 (es) 1977-04-01

Family

ID=4388903

Family Applications (7)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (es) 1973-09-12 1974-09-11 Un procedimiento para la preparacion de derivados de ben- cilpirimidina.
ES437011A Expired ES437011A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437009A Expired ES437009A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437007A Expired ES437007A1 (es) 1973-09-12 1975-04-25 Procedimiento para la preparacion de derivados de bencilpi- rimidina.
ES437012A Expired ES437012A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437008A Expired ES437008A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437013A Expired ES437013A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (es) 1973-09-12 1974-09-11 Un procedimiento para la preparacion de derivados de ben- cilpirimidina.
ES437011A Expired ES437011A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437009A Expired ES437009A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437007A Expired ES437007A1 (es) 1973-09-12 1975-04-25 Procedimiento para la preparacion de derivados de bencilpi- rimidina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES437008A Expired ES437008A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES437013A Expired ES437013A1 (es) 1973-09-12 1975-04-25 Un procedimiento para la preparacion de derivados de bencil-pirimidina.

Country Status (28)

Country Link
JP (1) JPS6042238B2 (es)
AR (2) AR207764A1 (es)
AT (1) AT338797B (es)
BE (1) BE819773A (es)
BR (1) BR7407614D0 (es)
CA (1) CA1037476A (es)
CH (1) CH591456A5 (es)
CU (1) CU34115A (es)
DD (2) DD122785A5 (es)
DE (1) DE2443682C2 (es)
DK (1) DK135683B (es)
ES (7) ES429949A1 (es)
FI (1) FI58638C (es)
FR (1) FR2242984B1 (es)
GB (3) GB1484482A (es)
HK (1) HK181A (es)
HU (1) HU170427B (es)
IE (1) IE40523B1 (es)
IL (1) IL45510A (es)
LU (1) LU70878A1 (es)
NL (1) NL155827B (es)
NO (1) NO140858C (es)
PH (1) PH10643A (es)
PL (2) PL97757B1 (es)
SE (1) SE419443B (es)
SU (3) SU577987A3 (es)
YU (3) YU217874A (es)
ZA (1) ZA745317B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH639273A5 (de) 1978-09-12 1983-11-15 Hoffmann La Roche Diuretische mittel.
CH664960A5 (de) * 1981-11-09 1988-04-15 Wellcome Found Verfahren zur herstellung von substituierten 2,4-diamino-5-benzylpyrimidinen.
DE3250132C2 (de) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc Verfahren zur Herstellung von 2,4-Diamino-5-benzyl-pyrimidinen und neue Zwischenprodukte des Verfahrens
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
JPH0431685Y2 (es) * 1987-06-01 1992-07-30
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (de) * 1957-02-21 1961-04-06 Wellcome Found Verfahren zur Herstellung von 2, 4-Diamino-5-benzylpyrimidinderivaten
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
GB1484483A (en) 1977-09-01
DD116824A5 (es) 1975-12-12
SE419443B (sv) 1981-08-03
GB1484481A (en) 1977-09-01
CH591456A5 (es) 1977-09-15
SU609465A3 (ru) 1978-05-30
DK135683B (da) 1977-06-06
CU21022L (en) 1981-09-09
FR2242984A1 (es) 1975-04-04
YU301680A (en) 1983-04-27
DK468374A (es) 1975-05-12
NL155827B (nl) 1978-02-15
SE7411382L (es) 1975-03-13
AR211387Q (es) 1977-12-15
FI256174A (es) 1975-03-13
PL97757B1 (pl) 1978-03-30
BR7407614D0 (pt) 1975-07-08
FR2242984B1 (es) 1977-11-04
ES437009A1 (es) 1977-04-01
LU70878A1 (es) 1976-08-19
IE40523L (en) 1975-03-12
JPS6042238B2 (ja) 1985-09-20
AR207764A1 (es) 1976-10-29
ATA735174A (de) 1977-01-15
FI58638B (fi) 1980-11-28
IL45510A (en) 1978-08-31
NL7411685A (nl) 1975-03-14
NO140858B (no) 1979-08-20
YU217874A (en) 1982-06-18
ES437011A1 (es) 1977-04-01
AU7263174A (en) 1976-02-26
ES437007A1 (es) 1977-04-01
ES429949A1 (es) 1976-10-01
JPS5053385A (es) 1975-05-12
CA1037476A (en) 1978-08-29
NO140858C (no) 1979-11-28
YU301580A (en) 1983-04-27
CU34115A (es) 1983-10-04
BE819773A (fr) 1975-03-11
HK181A (en) 1981-01-16
YU37153B (en) 1984-08-31
IL45510A0 (en) 1974-11-29
YU37154B (en) 1984-08-31
HU170427B (es) 1977-06-28
SU577987A3 (ru) 1977-10-25
GB1484482A (en) 1977-09-01
DK135683C (es) 1977-11-14
SU571189A3 (ru) 1977-08-30
AT338797B (de) 1977-09-12
FI58638C (fi) 1981-03-10
ES437013A1 (es) 1977-04-01
IE40523B1 (en) 1979-06-20
ZA745317B (en) 1975-11-26
DE2443682C2 (de) 1983-11-10
ES437008A1 (es) 1977-04-01
DE2443682A1 (de) 1975-03-20
DD122785A5 (es) 1976-11-05
NO743271L (es) 1975-04-07
PH10643A (en) 1977-07-22
PL99159B1 (pl) 1978-06-30

Similar Documents

Publication Publication Date Title
ES437012A1 (es) Un procedimiento para la preparacion de derivados de bencil-pirimidina.
ES419016A1 (es) Procedimiento para la produccion de compuesto del acido 13-bromo - lisergico.
ES397694A1 (es) Procedimiento para la preparacion de derivados de acidos tienil-imidazolil-grasos.
ES433723A1 (es) Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.
ES437612A1 (es) Procedimiento para la obtencion de una sal cuprica de accionantiinflamatoria.
ES373151A1 (es) Procedimiento para preparar acidos ciclohexa-2,4-dieno-ace-ticos.
ES431133A1 (es) Procedimiento de obtencion de derivados de la metil-1 (beta hidroxietil)-1 guanidina.
ES411993A1 (es) Un procedimiento de preparacion de derivados de ceto-acidosaromaticos.
ES362887A1 (es) Procedimiento para preparar un compuesto benzodiacepinico.
ES375883A1 (es) Procedimiento para la obtencion de derivados de los acidos ariloxiisobutiricos.
ES428011A1 (es) Procedimiento para la preparacion de 2-amino-3,5-dibromo- bencilamina.
ES427954A1 (es) Procedimiento para la preparacion de 2-amino - n - ciclohe-xil-3,5-dibromo - n - metil-bencilamina.
ES446295A1 (es) Procedimiento para la preparacion de acido 4-clorofenoxi-i- sobutiril-salicilico.
ES396747A1 (es) Un nuevo procedimiento para la obtencion de una sal 1,2,3,6-tetrahidro - 2,6-dioxo - 4 - piridin - carboxilato de 1- cinamid - 4 - difenil - metilpiperacina.
ES390039A1 (es) Un procedimiento para la preparacion de agentes antibacte- rianos.
ES356947A1 (es) Procedimiento de preparacion de compuestos de derivados ba-sicos con acidos benzopirrilaceticos.
ES373432A1 (es) Procedimiento para la preparacion de nuevos derivados del acido gama-trimetilamino - beta - hidroxibutirico con pro-piedades terapeuticas.
ES363847A1 (es) Procedimiento para la preparacion de nuevos derivados de tiepina.
ES382852A1 (es) Procedimiento para la preparacion de nuevos derivados de la5h-dibenz (b,f) azepina.
ES400122A1 (es) Procedimiento de preparacion del teofilinil - 7 - metil - etanoato de piridin-3-metanol.
ES358856A1 (es) Procedimiento para la obtencion de derivados de los acidos ariloxiisobutiricos.
ES395765A3 (es) Procedimiento para la obtencion de una sal del acido ace- tilsalicilico.
ES363079A1 (es) Procedimiento para la obtencion de sales de tetraciclina.
ES304696A3 (es) Un procedimiento para la preparaciën de nuevos derivados de fenotiazina
ES394942A1 (es) Un procedimiento para la preparacion de acidos 2-(6-metoxi-2'naftil) propionico y 2-(6-metoxi - 2 - naftil)-1-propanol.